RVMD
Revolution Medicines Inc
NASDAQ: RVMD · HEALTHCARE · BIOTECHNOLOGY
$140.55
-2.96% today
Updated 2026-04-29
Market cap
$29.88B
P/E ratio
—
P/S ratio
9,035.10x
EPS (TTM)
$-5.95
Dividend yield
—
52W range
$34 – $156
Volume
3.1M
Revolution Medicines Inc (RVMD) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
1 of 8
Last 8 quarters
Avg EPS surprise
-24.9%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-66.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-2.2%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-9.0%
2025-08-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-25 | $-1.86 | -17.7% | $104.83 | $102.15 | -2.6% |
| 2025-11-05 | $-1.61 | -14.2% | $58.57 | $61.38 | +4.8% |
| 2025-08-06 | $-1.31 | -17.0% | $38.39 | $34.95 | -9.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.58 | $-1.86 | -17.7% | — | — |
| 2025-09-30 | $-1.41 | $-1.61 | -14.2% | — | — |
| 2025-06-30 | $-1.12 | $-1.31 | -17.0% | — | — |
| 2025-03-31 | $-0.75 | $-1.13 | -50.7% | — | — |
| 2024-12-31 | $-0.96 | $-1.12 | -16.1% | $261.59M | +35155.0% |
| 2024-09-30 | $-0.89 | $-0.94 | -5.6% | — | — |
| 2024-06-30 | $-0.77 | $-0.81 | -5.2% | — | — |
| 2024-03-31 | $-0.75 | $-0.70 | +6.7% | — | — |
| 2023-12-31 | $-0.88 | $-1.14 | -29.5% | $742000.00 | — |
| 2023-09-30 | $-1.01 | $-0.99 | +2.0% | — | — |
| 2023-06-30 | $-0.82 | $-0.92 | -12.2% | $3.82M | — |
Analyst EPS and revenue estimates for upcoming years
| Period | EPS estimate | Revenue estimate | Revenue growth | Analysts | Confidence |
|---|---|---|---|---|---|
| 2026 (E) | $-7.47 | $0.1B | +-25.3% | 17 | high |
| 2027 (E) | $-6.48 | $0.3B | +408.7% | 17 | medium |
| 2030 (E) | $5.80 | $2.6B | +82.8% | 17 | low |
Frequently asked questions
Has Revolution Medicines Inc beaten earnings estimates?
Revolution Medicines Inc has beaten Wall Street EPS estimates in 1 of its last 8 quarterly reports, with an average EPS surprise of -24.9% over the last 4 quarters.
How does RVMD stock react to earnings?
RVMD stock has moved an average of -2.2% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is the expected EPS for RVMD in 2026?
Analysts expect Revolution Medicines Inc to report EPS of $-7.47 for fiscal year 2026, on revenue of $0.1B, based on estimates from 17 analysts.